DGAP-News: MeVis Medical Solutions AG: Changes in the Supervisory Board of MeVis Medical Solutions AG


DGAP-News: MeVis Medical Solutions AG / Key word(s): Change of
Personnel
MeVis Medical Solutions AG: Changes in the Supervisory Board of MeVis
Medical Solutions AG

16.04.2015 / 11:05

---------------------------------------------------------------------

  - Prof. Dr. Peitgen and Mr. Kuhlmann-Lehmkuhle resign from office in
    light of the acquisition of a majority stake by Varian Medical Systems

  - Succession candidates proposed

  - Dr. Kruse remains Supervisory Board Member

  - Election of two new Supervisory Board Members at the AGM on June 9th.

Bremen, April 16, 2015 - Prof. Dr. Heinz-Otto Peitgen, Chairman of the
Supervisory Board of MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], and
Mr. Peter Kuhlmann-Lehmkuhle, Member of the Supervisory Board of MeVis
Medical Solutions AG, informed the Company this past Friday that, in light
of the acquisition of a majority stake in the Company by VMS Deutschland
Holdings GmbH, they will resign from their respective offices effective as
of the end of the Annual General Meeting on June 9, 2015. Two succession
candidates with executive positions at Varian are being proposed.

Prof. Dr. Peitgen, Chairman of the Supervisory Board of MeVis Medical
Solutions AG since September 2006, is one of the founders of the Company
and has significantly influenced the development of MeVis Medical Solutions
AG to become one of the world's leading software companies in medical
imaging for diagnosis and treatment of cancer. During his time as Chairman
of the Supervisory Board, the IPO of MeVis Medical Solutions AG was
successfully implemented on November 16, 2007. Mr. Kuhlmann-Lehmkuhle has
been a Member of the Supervisory Board since June 2011.

"I founded MeVis with some of my employees in 1997 and accompanied it
through 18 years in good and in challenging times," says Prof. Dr. Peitgen.
"I am pleased that now, with me having reached the age of 70, MeVis, a
healthy company with excellent annual results, is in very good hands
through the acquisition of a majority of shares by Varian Medical Systems,
and thus has the opportunity to expand its position in the world market.
Today I thank especially the staff and the Executive Board, who have made
the company what it is today, and I wish them all the best for the future."

The Executive Board would like to thank Prof. Dr. Peitgen sincerely for
many years of extraordinary commitment as founder and Chairman of the
Supervisory Board of the Company. The Executive Board also thanks Mr.
Kuhlmann-Lehmkuhle for his constructive contributions over the past four
years.

The Supervisory Board has decided to propose Mr. Jörg Fässler and Mr. Glen
Hilton, both in responsible executive positions at Varian Medical Systems,
as Members of the Supervisory Board at the Annual General Meeting on June
9, 2015. Dr. Jens Kruse will remain a Member of the Supervisory Board.



---------------------------------------------------------------------

16.04.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                     
Company:     MeVis Medical Solutions AG                                  
             Caroline-Herschel-Str. 1                                    
             28359 Bremen                                                
             Germany                                                     
Phone:       +49 421 224 95 0                                            
Fax:         +49 421 224 95 999                                          
E-mail:      ir@mevis.de                                                 
Internet:    http://www.mevis.de                                         
ISIN:        DE000A0LBFE4                                                
WKN:         A0LBFE                                                      
Listed:      Regulated Market in Frankfurt (Prime Standard); Regulated   
             Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart  
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
344867 16.04.2015